Avirulent Uracil Auxotrophs Based on Disruption of Orotidine-5′-Monophosphate Decarboxylase Elicit Protective Immunity to Toxoplasma gondii
- 1 September 2010
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 78 (9), 3744-3752
- https://doi.org/10.1128/iai.00287-10
Abstract
The orotidine-5′-monophosphate decarboxylase (OMPDC) gene, encoding the final enzyme of the de novo pyrimidine biosynthesis pathway, was deleted using Toxoplasma gondii KU80 knockouts to develop an avirulent nonreverting pyrimidine auxotroph strain. Additionally, to functionally address the role of the pyrimidine salvage pathway, the uridine phosphorylase (UP) salvage activity was knocked out and a double knockout of UP and OMPDC was also constructed. The nonreverting ΔOMPDC, ΔUP, and ΔOMPDC ΔUP knockout strains were evaluated for pyrimidine auxotrophy, for attenuation of virulence, and for their ability to elicit potent immunity to reinfection. The ΔUP knockout strain was replication competent and virulent. In contrast, the ΔOMPDC and ΔOMPDC ΔUP strains were uracil auxotrophs that rapidly lost their viability during pyrimidine starvation. Replication of the ΔOMPDC strain but not the ΔOMPDC ΔUP strain was also partially rescued in vitro with uridine or cytidine supplementation. Compared to their hypervirulent parental type I strain, the ΔOMPDC and ΔOMPDC ΔUP knockout strains exhibited extreme attenuation in murine virulence (∼8 logs). Genetic complementation of the ΔOMPDC strain using a functional OMPDC allele restored normal replication and type I parental strain virulence phenotypes. A single immunization of mice with either the live critically attenuated ΔOMPDC strain or the ΔOMPDC ΔUP knockout strain effectively induced potent protective immunity to lethal challenge infection. The avirulent nonreverting ΔOMPDC and ΔOMPDC ΔUP strains provide new tools for the dissection of the host response to infection and are promising candidates for safe and effective Th1 vaccine platforms that can be easily genetically engineered.Keywords
This publication has 47 references indexed in Scilit:
- CD4 T-Cell Suppression by Cells fromToxoplasma gondii-Infected Retinas Is Mediated by Surface Protein PD-L1Infection and Immunity, 2010
- Long-Term Immunity to Lethal Acute or Chronic Type IIToxoplasma gondiiInfection Is Effectively Induced in Genetically Susceptible C57BL/6 Mice by Immunization with an Attenuated Type I Vaccine StrainInfection and Immunity, 2009
- Genetic identification of essential indels and domains in carbamoyl phosphate synthetase II of Toxoplasma gondiiInternational Journal for Parasitology, 2009
- Tagging of Endogenous Genes in aToxoplasma gondiiStrain Lacking Ku80Eukaryotic Cell, 2009
- Efficient Gene Replacements in Toxoplasma gondii Strains Deficient for Nonhomologous End JoiningEukaryotic Cell, 2009
- Host ER–parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii–infected dendritic cellsThe Journal of Experimental Medicine, 2009
- Presentation ofToxoplasma gondiiAntigens via the Endogenous Major Histocompatibility Complex Class I Pathway in Nonprofessional and Professional Antigen-Presenting CellsInfection and Immunity, 2007
- Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophagesThe Journal of Experimental Medicine, 2006
- Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutantsExperimental Parasitology, 1976
- TOXOPLASMIC ENCEPHALITIS IN CHILDRENJama-Journal Of The American Medical Association, 1941